Statistical inference on survival data in group-parallel clinical trials with treatment switching

Chang Ding, Siu-keung Tse and Ronghai Yang

Computational Statistics & Data Analysis, 2013, vol. 64, issue C, 269-280

Abstract: Usually patients are allowed to switch their treatments in clinical trials out of an ethical consideration. This complicates the modeling of the trial, as well as the analyzing process of the collected data. For group-parallel clinical trials which contain two groups (one is the test and the other is the control) and where all patients may switch their treatments, some statistical inferences on patients’ survival data are conducted. The median survival times for two treatments are estimated by the maximum likelihood method. Furthermore, the hypothesis test on equality, superiority/non-inferiority and equivalence of two median survival times as well as the confidence interval estimation for the difference of two medians are also discussed. The sample size required in designing each hypothesis test is derived. Also a numerical study is conducted to assess the performance of the proposed approaches.

Keywords: Clinical trial; Group-parallel design; Treatment switching; Censoring; Latent survival time (search for similar items in EconPapers)
Date: 2013
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167947313000716
Full text for ScienceDirect subscribers only.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:csdana:v:64:y:2013:i:c:p:269-280

DOI: 10.1016/j.csda.2013.02.015

Access Statistics for this article

Computational Statistics & Data Analysis is currently edited by S.P. Azen

More articles in Computational Statistics & Data Analysis from Elsevier
Bibliographic data for series maintained by Catherine Liu ().